Opseu Pension Plan Trust Fund Vertex Pharmaceuticals Inc Transaction History

Opseu Pension Plan Trust Fund

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$273.83 - $305.53 $16,977 - $18,942	62 Added 0.73%	8,500 $2.51 Million
Q2 2022 Aug 11, 2022	BUY	$234.96 - $292.55 $732,840 - $912,463	3,119 Added 58.64%	8,438 $2.36 Million
Q1 2022 May 09, 2022	BUY	$221.42 - $260.97 $40,962 - $48,279	185 Added 3.6%	5,319 $1.39 Million
Q4 2021 Feb 10, 2022	BUY	$177.01 - $223.45 $3,540 - $4,469	20 Added 0.39%	5,134 $1.14 Million
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $23,580 - $26,388	-130 Reduced 2.48%	5,114 $921,000
Q2 2021 Aug 11, 2021	BUY	$187.49 - $221.1 $983,197 - $1.16 Million	5,244 New	5,244 $1.06 Million

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Opseu Pension Plan Trust Fund, based on Form 13F filings with the SEC.

Stay updated on Opseu Pension Plan Trust Fund with notifications on news.